Hey! It’s time for a quick and efficient COVID-19 round up (June 2023)!
In this round-up you will find information about:
- The recent end of the PHEIC and what it means.
- The current situation in Canada.
- What to expect in the next months
- The sub-variants currently circulating
- Updated and new vaccines
- Recommendation for booster
- Research development on Long COVID.
Feel free to navigate directly to the slide that interests you the most, and save the rest to revisit later.
Share our original Tweet!
Hey, it’s time for a quick and efficient COVID-19 round up (June 2023)! https://t.co/ZxyAzniSM6
Did we miss something? Let us know in the comments.#ScienceUpFirst pic.twitter.com/KpSNNI9PMX
— ScienceUpFirst | LaScienced’Abord (@ScienceUpFirst) June 29, 2023
View our original Instagram Post!
View this post on Instagram
Sources
- Statement on the fifteenth meeting of the IHR (2005) Emergency Committee on the COVID-19 pandemic | FR : Déclaration sur la quinzième réunion du Comité d’urgence du Règlement sanitaire international (2005) concernant la pandémie de maladie à coronavirus 2019 (COVID-19)
- COVID-19 epidemiology update: Summary | FR : Mise à jour sur l’épidémiologie de la COVID-19 : Résumé
- COVID-19 epidemiology update: Current situation | FR : Mise à jour sur l’épidémiologie de la COVID-19 : Mise à jour courante
- What’s Going On With Covid Right Now?
- Will COVID’s Spring Lull Last?
- One year since the emergence of COVID-19 virus variant Omicron
- COVID-19 variants of concern
- About Variants | FR : À propos des variants
- Données sur les variants du SRAS-CoV-2 au Québec
- Guidance on an additional COVID-19 booster dose in the spring of 2023 for individuals at high risk of severe illness due to COVID-19 | FR : Directives sur une dose de rappel supplémentaire du vaccin contre la COVID-19 au printemps 2023 pour les personnes présentant un risque élevé de maladie sévère due à la COVID-19
- Tracking SARS-CoV-2 variants | FR : Suivi des variants du SARS-CoV-2
- Les variants du SRAS-CoV-2
- Interim guidance on the use of bivalent Omicron containing COVID-19 vaccines for primary series
- FR : Directives provisoires sur l’utilisation de vaccins bivalents contre la COVID-19 contenant Omicron dans le cadre d’une série primaire
- Neutralization escape of Omicron XBB, BR.2, and BA.2.3.20 subvariants
- Statement on the antigen composition of COVID-19 vaccines
- COVID shots should target XBB variants in 2023-24 campaign, US FDA staff say
- New COVID vaccines should only target dominant XBB variants: WHO
- Progress on Intranasal & Oral Covid Vaccines
- A mucosal vaccine could be a COVID-19 game-changer. So why doesn’t Canada have one?
- COVID-19 vaccine: Canadian Immunization Guide | FR : Vaccin contre la COVID-19 : Guide canadien d’immunisation
- SAGE updates COVID-19 vaccination guidance | FR : Le SAGE met à jour les orientations relatives à la vaccination contre la COVID-19
- Development of a Definition of Postacute Sequelae of SARS-CoV-2 Infection
- Recovery and symptom trajectories up to two years after SARS-CoV-2 infection: population based, longitudinal cohort study
- Long COVID: major findings, mechanisms and recommendations
- Impact of Vaccination on Major Adverse Cardiovascular Events in Patients With COVID-19 Infection
- Association of COVID-19 Vaccination With Risk for Incident Diabetes After COVID-19 Infection | Infectious Diseases
- The Trend of Myocarditis in Mississippi Before and During the Covid-19 Pandemic Era
- Long COVID risk and pre-COVID vaccination in an EHR-based cohort study from the RECOVER program
- Post-COVID-19 condition (long COVID) | FR : Syndrome post-COVID-19 (COVID longue)
- How to Reduce Risk of Getting Long COVID
